Public Release: 

PharmSci 360: Monday's program highlights

American Association of Pharmaceutical Scientists

Highlights from Monday, Nov. 5 program include:

9:30 a.m. - 10:30 a.m.

  • A New Immunoaffinity Extraction Method for Rapid Diagnosis of Paralytic Shellfish Poisoning in Humans
    Bioanalytics, Poster Forum 4

  • Development and Characterization of an Antibiotic-Eluting Bone Void Filling (ABVF) Putty for Osteomyelitis Treatment
    Formulation and Quality, Poster Forum 8

10:30 a.m. - 11:30 a.m.

  • Elucidating the Two-Step Targeting Mechanism of Polymer Lipid Hybrid Nanoparticles for Shuttling Trastuzumab across the Blood Brain Barrier to Treat Brain Metastasis of HER2-Positive Breast Cancer
    Manufacturing and Bioprocessing, Poster Forum 6

12:30 p.m. - 1:30 p.m.

  • Optimization of Penfluridol for Use in Lung Cancer Therapy
    Preclinical Development, Poster Forum 1

  • Development and Validation of a PBPK Model to Predict Plasma and Sputum Exposures after IV, Oral or Inhalation Administration of Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients
    Clinical Pharmacology, Poster Forum 5

1:30 p.m. - 2:30 p.m.

  • Candidate Selection or Preclinical Evaluation of ADC and Immunotherapy Combination
    Shyra Gardai, Ph.D., Director, Head of Immunology, Seattle Genetics
    Room 207 A

  • Engineering First Principles Applications to Pharmaceutical Manufacturing
    Bernard McGarvey, Ph.D., Retired Engineering Fellow, Eli Lilly and Company
    Ballroom B

  • FDA Perspective on Development of Drug-Device Combination Products
    Ashley Boam, Director, Office of Policy for Pharmaceutical Quality, FDA/CDER/OPQ
    Ballroom C

  • The Evolution of Modeling & Simulation in Drug Development and Regulatory Applications
    Malcolm Rowland, Ph.D., DSc, Professor Emeritus, University of Manchester
    Ballroom A

  • The Expanding Frontier of Bioanalysis: New Modalities
    Binodh DeSilva, Ph.D., Vice President, Bristol-Myers Squibb
    Room 207 B


About AAPS:

The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Visit and follow us on LinkedIn, Facebook and Twitter @AAPSComms. The official Twitter hashtags for AAPS are: #AAPS2018 and #PharmSci360.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.